Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001962918-24-000106
Filing Date
2024-08-13
Accepted
2024-08-13 16:18:31
Documents
77
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q slrn-20240630.htm   iXBRL 10-Q 1630595
2 EX-31.1 slrn-20240630x10qexx311.htm EX-31.1 9474
3 EX-31.2 slrn-20240630x10qexx312.htm EX-31.2 9547
4 EX-32 slrn-20240630x10qexx321.htm EX-32 6160
  Complete submission text file 0001962918-24-000106.txt   7690755

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT slrn-20240630.xsd EX-101.SCH 60484
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT slrn-20240630_cal.xml EX-101.CAL 74502
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT slrn-20240630_def.xml EX-101.DEF 290025
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT slrn-20240630_lab.xml EX-101.LAB 619053
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT slrn-20240630_pre.xml EX-101.PRE 474555
80 EXTRACTED XBRL INSTANCE DOCUMENT slrn-20240630_htm.xml XML 962734
Mailing Address 4149 LIBERTY CANYON RD. AGOURA HILLS CA 91301
Business Address 4149 LIBERTY CANYON RD. AGOURA HILLS CA 91301 805-871-4300
ACELYRIN, Inc. (Filer) CIK: 0001962918 (see all company filings)

EIN.: 852406735 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41696 | Film No.: 241201768
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)